Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis
Clinical trial NCT05636891 · COMPLETED
Trial details
- NCT number
- NCT05636891
- Sponsor
- Nanogen Pharmaceutical Biotechnology Joint Stock Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-19
- Primary completion
- 2022-11-23
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.